Clinical Management of Multidrug-Resistant Tuberculosis in 16 European Countries

Keyphrases

• European Countries 100%
• Clinical Management 100%
• Multidrug-resistant Tuberculosis (MDR-TB) 100%
• High Incidence 57%
• Treatment Outcome 42%
• Europe 42%
• World Health Organization 42%
• Outcome Definition 42%
• Organizational Outcomes 28%
• Failure Rate 28%
• Management Outcome 28%
• Treatment Regimen 14%
• End of Treatment 14%
• Prospective Cohort Study 14%
• Treatment Initiation 14%
• Increased Mortality 14%
• Treatment Efficacy 14%
• Treatment Delay 14%
• Public Health 14%
• Relapse-free 14%
• Cure Rate 14%
• Tuberculosis 14%
• Tuberculosis Treatment 14%
• Drug Resistance 14%
• Pyrazinamide 14%
• Individualized Treatment 14%
• Low-incidence Country 14%

Medicine and Dentistry

• Clinical Management 100%
• Multidrug Resistant Tuberculosis 100%
• Prospective Cohort Study 14%
• Public Health 14%
• Tuberculosis Treatment 14%
• Drug Resistance 14%
• Pyrazinamide 14%